• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[促性腺激素释放激素激动剂治疗性早熟。使用缓释剂型的D-色氨酸-6-促性腺激素释放激素的多中心研究]

[Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].

作者信息

Roger M, Chaussain J L, Bost M, Bozzola M, Colle M, Despert F, François R, Freycon F, Garandeau P, Malpuech G

出版信息

Rev Fr Gynecol Obstet. 1986 May;81(5):297-305.

PMID:2943013
Abstract

LH-RH analogs, substituted in position 6 by D-tryptophane, D-serine(tBu), D-leucine or D-alanine induce a strong stimulation of the gonadotrophs, followed by a desensitization of the LH-RH receptors, which leads to a blockade of the gonadotropin secretion and to a hypogonadism. A delayed release preparation of D-Trp-6-LH-RH (Decapeptyl in microcapsules), designed to release the peptide for 28 days after intramuscular injection, was given to 69 girls and 18 boys with precocious puberty. In both, plasma levels of gonadotropins and gonadal steroids were suppressed within 3 weeks, whilst pituitary responses to LH-RH were almost abolished within 7 weeks. A significant improvement of secondary sex characteristics, as well as gonadal size, was obvious within 6 months. Growth velocity was markedly lowered and, more, in most of children, bone maturation was blocked. This study shows that Decapeptyl in microcapsules is more rapidly and more constantly efficient than LH-RH agonists given discontinuously by subcutaneous or intranasal route.

摘要

在第6位被D-色氨酸、D-丝氨酸(叔丁基)、D-亮氨酸或D-丙氨酸取代的促黄体生成素释放激素(LH-RH)类似物可强烈刺激促性腺细胞,随后导致LH-RH受体脱敏,进而阻断促性腺激素分泌并导致性腺功能减退。将一种设计为在肌肉注射后28天释放该肽的D-色氨酸-6-LH-RH缓释制剂(微囊化的达必佳)给予69名女孩和18名患有性早熟的男孩。在这两组患者中,促性腺激素和性腺类固醇的血浆水平在3周内受到抑制,而垂体对LH-RH的反应在7周内几乎完全消失。6个月内,第二性征以及性腺大小有明显改善。生长速度明显降低,而且在大多数儿童中,骨成熟被阻断。这项研究表明,微囊化的达必佳比通过皮下或鼻内途径间断给药的LH-RH激动剂起效更快且效果更持久。

相似文献

1
[Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].[促性腺激素释放激素激动剂治疗性早熟。使用缓释剂型的D-色氨酸-6-促性腺激素释放激素的多中心研究]
Rev Fr Gynecol Obstet. 1986 May;81(5):297-305.
2
[Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH)].
J Steroid Biochem. 1989 Oct;33(4B):805-8. doi: 10.1016/0022-4731(89)90497-4.
3
[Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
Bull Acad Natl Med. 1988 Nov;172(8):1091-8.
4
Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.通过定期给予长效D-色氨酸6-促黄体生成素释放激素微胶囊制剂对男性和女性性早熟进行长期治疗。
J Clin Endocrinol Metab. 1986 Apr;62(4):670-7. doi: 10.1210/jcem-62-4-670.
5
The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.美国国立卫生研究院(NIH)对性早熟的研究经验:诊断亚组及对短期促黄体生成素释放激素类似物治疗的反应
J Pediatr. 1986 Jan;108(1):47-54. doi: 10.1016/s0022-3476(86)80767-3.
6
Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.用强效促黄体生成素释放因子激动剂治疗真性性早熟:对生长、性成熟、盆腔超声检查及下丘脑-垂体-性腺轴的影响。
J Clin Endocrinol Metab. 1985 Jul;61(1):142-51. doi: 10.1210/jcem-61-1-142.
7
Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
J Pediatr. 1986 Dec;109(6):954-8. doi: 10.1016/s0022-3476(86)80275-x.
8
Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.真性性早熟女孩在促性腺激素释放激素激动剂治疗期间的骨质流失并非由于降钙素分泌受损所致。
J Endocrinol Invest. 1991 Mar;14(3):231-6. doi: 10.1007/BF03346798.
9
Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma.采用缓释制剂的 D-色氨酸-6-促黄体生成素释放激素(曲普瑞林)单次肌内注射对前列腺癌患者垂体-性腺轴的抑制作用。
Prostate. 1989;14(4):291-300. doi: 10.1002/pros.2990140402.
10
Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.促黄体生成素释放激素类似物治疗患有下丘脑错构瘤和真性性早熟的男孩。
J Clin Endocrinol Metab. 1984 Nov;59(5):888-92. doi: 10.1210/jcem-59-5-888.

引用本文的文献

1
DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation.DNA甲基转移酶1通过诱导MEG3高甲基化促进乳腺癌生长。
Cancer Cell Int. 2022 Feb 2;22(1):56. doi: 10.1186/s12935-022-02463-8.
2
Transgender medicine - puberty suppression. transgender 医学-青春期抑制。
Rev Endocr Metab Disord. 2018 Sep;19(3):221-225. doi: 10.1007/s11154-018-9457-0.